Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Iglu Sugar Free Pastilles

Active Ingredient:
benzalkonium chloride solution , compound benzoin tincture
Company:  
Diomed Developments Limited See contact details
About Medicine
{medical_services}
General Sales List
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 11 Dec 2020
{pdf} View or print the patient leaflet as PDF

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL 0094/5016R.

{printer} Print patient leaflet as text only

Iglu Sugar Free Pastilles

PACKAGE LEAFLET Information for the user

iglü® sugar free pastilles

Benzalkonium Chloride Solution 1.11 mg and Compound Benzoin Tincture 8.06 mg

Please read all of this leaflet carefully before you start taking this medicine.

Keep this leaflet. You may need to read it again. Ask your doctor, dentist or pharmacist if you need more information or advice. You must contact a doctor or dentist if your symptoms worsen or do not improve after 7 days. If any of the side effects get serious, or if you notice any side effect not listed in this leaflet (see section 4), please tell your doctor, dentist or pharmacist.

In this leaflet:

1. What Iglü Sugar Free Pastilles are and what they are used for
2. Before you take Iglü Sugar Free Pastilles
3. How to take Iglü Sugar Free Pastilles
4. Possible side effects
5. How to store Iglü Sugar Free Pastilles
6. Further information

1. WHAT IGLÜ SUGAR FREE PASTILLES ARE AND WHAT THEY ARE USED FOR
  • Iglü Sugar Free Pastilles contain the active ingredients benzalkonium chloride solution and compound benzoin tincture which have antiseptic properties.
  • These pastilles ease discomfort and bring soothing relief to mouth ulcers and sore gums.
  • Iglü Sugar Free Pastilles are suitable for use by adults, the elderly and children over 3 years of age.

2. BEFORE YOU TAKE IGLÜ SUGAR FREE PASTILLES

Do not take Iglü Sugar Free Pastilles if you are allergic (hypersensitive) to benzalkonium chloride solution, compound benzoin tincture or any of the other ingredients in this medicine as listed in Section 6.

Do not give to children under 3 years.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, talk to your doctor or pharmacist before using this medicine.

Driving and using machinery

Using this product is not known to affect your ability to drive or use machinery.

Important information about some of the ingredients of this medicine
  • This medicine contains 1.11mg benzalkonium chloride in each lozenge. Benzalkonium chloride may cause local irritation.
  • This medicine contains 363.3 mg sorbitol in each lozenge. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.

3. HOW TO TAKE IGLÜ SUGAR FREE PASTILLES

Always take Iglü Sugar Free Pastilles by mouth.

For adults, the elderly and children over 3 years.
  • Dissolve one pastille in the mouth every 2 hours.
  • Do not take more than 8 pastilles in 24 hours.
  • Do not give to children under 3 years.

If you take too many pastilles

overdosage of the active ingredient is unlikely to occur because of the low concentrations used and the small pack size. If the dosage is grossly exceeded, sickness/nausea and vomiting may occur. If this happens you should seek medical advice.

If you occasionally forget to take Iglü Sugar Free Pastilles do not worry, just carry on using them when you remember.

If you have any further questions on the use of this medicine, ask your doctor, dentist or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Iglü Sugar Free Pastilles can cause side effects, although not everyone gets them.

On rare occasions, hypersensitivity reactions to benzalkonium chloride occur involving difficulty in breathing, swelling of the face, neck, tongue or throat and a rash (severe allergic reactions). Stop taking this medicine and seek urgent medical attention if you experience these symptoms.

Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE IGLÜ SUGAR FREE PASTILLES
  • Keep out of the sight and reach of children.
  • Do not use Iglü Sugar Free Pastilles after the ‘Use by’ date (last day of the month) printed on the carton.
  • Do not store above 25˚C. Store in the original package in order to protect from moisture.
  • Medicines should not be disposed of via wastewater or household waste.
    Ask your pharmacist how to dispose of medicines you no longer use.
    These measures will help to protect the environment.

6. FURTHER INFORMATION
What Iglü Sugar Free Pastilles contain:

Each pastille contains the active ingredients benzalkonium chloride solution 1.11 mg and compound benzoin tincture 8.06 mg.

The other ingredients are sorbitol liquid (non crystallising), acacia, peppermint oil, simethicone antifoam, vegetable oil, carnauba wax, water.

What Iglü Sugar Free Pastilles look like and contents of the pack
  • They are round light brown, flat pastilles.
  • They are available in blister strips of 12.
  • Each pack contains 24 pastilles (2 blister strips x 12).
The Marketing Authorisation Holder and Manufacturer is:
Ernest Jackson & Co. Ltd
Crediton
Devon
EX17 3AP
UK

for

Diomed Developments Ltd
Hitchin
Herts
SG4 7QR
UK

This leaflet was last revised in

May 2020.

Other formats – To request a copy of this leaflet in Braille, large print or audio please call 01363 636000.

PL 00094/5016R

Diomed Developments Limited
Company image
Address
Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone
+44 (0)1462 458 866
WWW
www.diomedgroup.co.uk